[New molecular targeted EML4-ALK for lung cancer].
Mano
Hiroyuki
H
D000077548:Anaplastic Lymphoma Kinase; D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000032:analysis*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D020794:Receptor Protein-Tyrosine Kinases
C522504:EML4-ALK fusion protein, human; D015514:Oncogene Proteins, Fusion; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases